Indeed, John et al. demonstrated that inhibition of adipocyte differentiation by the loss of SPARC curtailed ovarian cancer growth, their migration, invasion, and homing to adipose-rich niches as well as inhibited ovarian cancer cell metabolic reprogramming [110]. Here, SPARC is linked to ovarian carcinoma.